Advertisement
Advertisement
U.S. markets open in 7 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Algernon Pharmaceuticals Inc. (AGNPF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
3.1500+0.3400 (+12.10%)
At close: 01:29PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.8100
Open3.0600
BidN/A x N/A
AskN/A x N/A
Day's Range2.9407 - 3.2000
52 Week Range2.3015 - 9.2900
Volume1,797
Avg. Volume2,089
Market Cap6.25M
Beta (5Y Monthly)0.46
PE Ratio (TTM)N/A
EPS (TTM)-2.2770
Earnings DateApr 27, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AGNPF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ALGERNON PHARMACEUTICALS INC
    Analyst Report: CVS Health CorporationFollowing its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
Advertisement
Advertisement